A new promising risk stratifying tool based on combination of lymphovascular invasion and systemic immune-inflammation index to predict the survival and to help evaluate the potential benefit of adjuvant chemotherapy for upper tract urothelial carcinoma

Subjects

Subjects :

Diseases of the genitourinary system. Urology
RC870-923
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Details

Language :

English

ISSN :

26661683

Volume :

19

Issue :

e325-

Database :

Directory of Open Access Journals

Journal :

European Urology Open Science

Publication Type :

Academic Journal

Accession number :

edsdoj.fd2e6bcd1cc044b78c05c82b0811a899

Document Type :

article

Full Text :

https://doi.org/10.1016/S2666-1683(20)32773-7